Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Antiviral Res. 2008 Feb 13;78(3):230–241. doi: 10.1016/j.antiviral.2008.01.007

Fig. 1.

Fig. 1

Time-course of TC-83 VEEV titer in brain (A), spleen (C), liver (D), kidney (E), and serum (F) taken from infected mice on various days after i.n. viral challenge and titrated by infectious cell culture assay. Titers were also determined by QRT-PCR in brains (B) of mice infected 2, 4, 6, and 8 dpi.